Medical school awarded $53 million to improve translational medicine

The Stanford School of Medicine has received a five-year, $53 million grant renewal from the Clinical and Translational Science Award Program.

Courtesy: Bio-X

The CTSA Program is overseen by the National Center for Advancing Translational Sciences at the National Institutes of Health.

“This funding will help us strengthen our clinical and translational research infrastructure in a way that will prepare us for the remarkable transformation underway in precision health and population health research,” said MARK CULLEN, senior associate vice provost for research at Stanford and senior associate dean for research at the School of Medicine. “Ultimately, this will accelerate the application of research discoveries into clinical care, helping people live longer, healthier lives.”

With the grant renewal, Stanford will continue its collaborations with a national network of 50-plus academic medical research institutions, known as CTSA Program hubs. The hubs work together to share resources and improve the processes that turn research discoveries into medical treatments and cures.

The NIH launched the CTSA Program in 2006 to incentivize research institutions to find creative ways to more rapidly move breakthroughs in basic research to patient care.

The university previously received CTSA Program grants in 2008 and 2013, with the latter grant totaling $45 million.

Read the full article and learn more about the CTSA program on the Stanford School of Medicine website.